Last 12 months
Inside the activity.
1 purchase rows · 42 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 12 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 11 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 1 | 6 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 25, 2021 Filed Mar 29, 2021 23:47 UTC |
KINDLER JEFFREY BDirector
|
GrantRestricted Stock Units · Derivative | 16,212 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-000566 · edgar.xml · derivative · entry 2 KINDLER JEFFREY B · CIK 0001174454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,212 Underlying: Common Stock · 16,212 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Precigen Inc. common stock. F3 · derivative.exercise_date: The restricted stock units vest in full on March 25, 2022. F3 · derivative.expiration_date: The restricted stock units vest in full on March 25, 2022. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 23:47 UTC |
KINDLER JEFFREY BDirector
|
GrantCommon Stock | 8,949 | $7.71 | $68,996.79 |
DisclosureSEC source: 0001123292-21-000566 · edgar.xml · nonDerivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,209 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $69,000. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 19:45 UTC |
Gupta Vinita DDirector
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 22,107 | $0.00 Strike: $7.71 | $0.00 |
DisclosureSEC source: 0001123292-21-000564 · edgar.xml · derivative · entry 4 Gupta Vinita D · CIK 0001705209 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,107 Underlying: Common Stock · 22,107 shares Expires 2031-03-25 Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 19:45 UTC |
Gupta Vinita DDirector
|
GrantRestricted Stock Units · Derivative | 16,212 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-000564 · edgar.xml · derivative · entry 3 Gupta Vinita D · CIK 0001705209 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,212 Underlying: Common Stock · 16,212 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Precigen, Inc. common stock. F4 · derivative.exercise_date: The restricted stock units vest in full on March 25, 2022. F4 · derivative.expiration_date: The restricted stock units vest in full on March 25, 2022. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 19:45 UTC |
Gupta Vinita DDirector
|
GrantCommon Stock | 7,328 | $7.71 | $56,498.88 |
DisclosureSEC source: 0001123292-21-000564 · edgar.xml · nonDerivative · entry 1 Gupta Vinita D · CIK 0001705209 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,820 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $56,500. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 23:54 UTC |
Perez Jeffrey ThomasSVP, IP Affairs
|
GrantRestricted Stock Units · Derivative | 22,697 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-000572 · edgar.xml · derivative · entry 1 Perez Jeffrey Thomas · CIK 0001617812 · SVP, IP Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,697 Underlying: Common Stock · 22,697 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen Common Stock. F2 · derivative.exercise_date: The RSUs vest in full on May 14, 2021. F2 · derivative.expiration_date: The RSUs vest in full on May 14, 2021. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 23:53 UTC |
Sabzevari HelenDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 97,276 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-000571 · edgar.xml · derivative · entry 1 Sabzevari Helen · CIK 0001724195 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,276 Underlying: Common Stock · 97,276 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: The RSUs vest in full on May 12, 2021. F2 · derivative.expiration_date: The RSUs vest in full on May 12, 2021. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 23:51 UTC |
Lehr Donald P.Chief Legal Officer
|
GrantRestricted Stock Units · Derivative | 26,102 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-000570 · edgar.xml · derivative · entry 1 Lehr Donald P. · CIK 0001583187 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,102 Underlying: Common Stock · 26,102 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: The RSUs vest in full on May 18, 2021. F2 · derivative.expiration_date: The RSUs vest in full on May 18, 2021. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 23:50 UTC |
Turley James SDirector
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 22,107 | $0.00 Strike: $7.71 | $0.00 |
DisclosureSEC source: 0001123292-21-000569 · edgar.xml · derivative · entry 3 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,107 Underlying: Common Stock · 22,107 shares Expires 2031-03-25 Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 23:50 UTC |
Turley James SDirector
|
GrantRestricted Stock Units · Derivative | 16,212 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-000569 · edgar.xml · derivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,212 Underlying: Common Stock · 16,212 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Precigen, Inc. common stock. F3 · derivative.exercise_date: The restricted stock units vest in full on March 25, 2022. F3 · derivative.expiration_date: The restricted stock units vest in full on March 25, 2022. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 23:50 UTC |
Turley James SDirector
|
GrantCommon Stock | 8,106 | $7.71 | $62,497.26 |
DisclosureSEC source: 0001123292-21-000569 · edgar.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,904 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $62,500. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 23:48 UTC |
MITCHELL DEAN JDirector
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 22,107 | $0.00 Strike: $7.71 | $0.00 |
DisclosureSEC source: 0001123292-21-000567 · edgar.xml · derivative · entry 3 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,107 Underlying: Common Stock · 22,107 shares Expires 2031-03-25 Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 23:48 UTC |
MITCHELL DEAN JDirector
|
GrantRestricted Stock Units · Derivative | 16,212 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-000567 · edgar.xml · derivative · entry 2 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,212 Underlying: Common Stock · 16,212 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Precigen, Inc. common stock. F3 · derivative.exercise_date: The restricted stock units vest in full on March 25, 2022. F3 · derivative.expiration_date: The restricted stock units vest in full on March 25, 2022. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 23:48 UTC |
MITCHELL DEAN JDirector
|
GrantCommon Stock | 7,328 | $7.71 | $56,498.88 |
DisclosureSEC source: 0001123292-21-000567 · edgar.xml · nonDerivative · entry 1 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,926 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $56,500. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 23:44 UTC |
Frank StevenDirector
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 22,107 | $0.00 Strike: $7.71 | $0.00 |
DisclosureSEC source: 0001123292-21-000563 · edgar.xml · derivative · entry 3 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,107 Underlying: Common Stock · 22,107 shares Expires 2031-03-25 Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 23:44 UTC |
Frank StevenDirector
|
GrantRestricted Stock Units · Derivative | 16,212 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-000563 · edgar.xml · derivative · entry 2 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,212 Underlying: Common Stock · 16,212 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Precigen, Inc. common stock. F3 · derivative.exercise_date: The restricted stock units vest in full on March 25, 2022. F3 · derivative.expiration_date: The restricted stock units vest in full on March 25, 2022. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 23:44 UTC |
Frank StevenDirector
|
GrantCommon Stock | 6,485 | $7.71 | $49,999.35 |
DisclosureSEC source: 0001123292-21-000563 · edgar.xml · nonDerivative · entry 1 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337,205 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $50,000. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 23:43 UTC |
ALVAREZ CESAR LDirector
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 22,107 | $0.00 Strike: $7.71 | $0.00 |
DisclosureSEC source: 0001123292-21-000562 · edgar.xml · derivative · entry 3 ALVAREZ CESAR L · CIK 0001220297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,107 Underlying: Common Stock · 22,107 shares Expires 2031-03-25 Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 23:43 UTC |
ALVAREZ CESAR LDirector
|
GrantRestricted Stock Units · Derivative | 16,212 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-000562 · edgar.xml · derivative · entry 2 ALVAREZ CESAR L · CIK 0001220297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,212 Underlying: Common Stock · 16,212 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Precigen, Inc. common stock. F3 · derivative.exercise_date: The restricted stock units vest in full on March 25, 2022. F3 · derivative.expiration_date: The restricted stock units vest in full on March 25, 2022. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 23:43 UTC |
ALVAREZ CESAR LDirector
|
GrantCommon Stock | 8,106 | $7.71 | $62,497.26 |
DisclosureSEC source: 0001123292-21-000562 · edgar.xml · nonDerivative · entry 1 ALVAREZ CESAR L · CIK 0001220297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,396 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $62,500. Read SEC document |
| March 13, 2021 Filed Mar 16, 2021 16:32 UTC |
SHAPIRO ROBERT BDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 62,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-000484 · edgar.xml · derivative · entry 3 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,189 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen, Inc. common stock. F3 · derivative.exercise_date: The RSUs vested in full on March 13, 2021. F3 · derivative.expiration_date: The RSUs vested in full on March 13, 2021. Read SEC document |
| March 13, 2021 Filed Mar 16, 2021 16:32 UTC |
SHAPIRO ROBERT BDirector
|
Exercise / conversionCommon Stock | 62,189 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-000484 · edgar.xml · nonDerivative · entry 1 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen, Inc. common stock. Read SEC document |
| March 13, 2021 Filed Mar 16, 2021 20:35 UTC |
Hassan FredDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 62,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-000487 · edgar.xml · derivative · entry 2 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,189 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen, Inc. common stock. F2 · derivative.exercise_date: The RSUs vested in full on March 13, 2021. F2 · derivative.expiration_date: The RSUs vested in full on March 13, 2021. Read SEC document |
| March 13, 2021 Filed Mar 16, 2021 20:35 UTC |
Hassan FredDirector
|
Exercise / conversionCommon Stock | 62,189 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-000487 · edgar.xml · nonDerivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,359 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen, Inc. common stock. Read SEC document |
| March 13, 2021 Filed Mar 16, 2021 20:34 UTC |
KINDLER JEFFREY BDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 62,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-000486 · edgar.xml · derivative · entry 2 KINDLER JEFFREY B · CIK 0001174454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,189 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen, Inc. common stock. F2 · derivative.exercise_date: The RSUs vested in full on March 13, 2021. F2 · derivative.expiration_date: The RSUs vested in full on March 13, 2021. Read SEC document |
| March 13, 2021 Filed Mar 16, 2021 20:34 UTC |
KINDLER JEFFREY BDirector
|
Exercise / conversionCommon Stock | 62,189 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-000486 · edgar.xml · nonDerivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,260 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen, Inc. common stock. Read SEC document |
| March 13, 2021 Filed Mar 16, 2021 16:36 UTC |
Gupta Vinita DDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 62,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-000489 · edgar.xml · derivative · entry 3 Gupta Vinita D · CIK 0001705209 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,189 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen, Inc. common stock. F3 · derivative.exercise_date: The RSUs vested in full on March 13, 2021. F3 · derivative.expiration_date: The RSUs vested in full on March 13, 2021. Read SEC document |
| March 13, 2021 Filed Mar 16, 2021 16:36 UTC |
Gupta Vinita DDirector
|
Exercise / conversionCommon Stock | 62,189 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-000489 · edgar.xml · nonDerivative · entry 1 Gupta Vinita D · CIK 0001705209 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen, Inc. common stock. Read SEC document |
| March 13, 2021 Filed Mar 16, 2021 20:38 UTC |
ALVAREZ CESAR LDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 62,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-000491 · edgar.xml · derivative · entry 2 ALVAREZ CESAR L · CIK 0001220297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,189 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen, Inc. common stock. F2 · derivative.exercise_date: The RSUs vested in full on March 13, 2021. F2 · derivative.expiration_date: The RSUs vested in full on March 13, 2021. Read SEC document |
| March 13, 2021 Filed Mar 16, 2021 20:38 UTC |
ALVAREZ CESAR LDirector
|
Exercise / conversionCommon Stock | 62,189 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-000491 · edgar.xml · nonDerivative · entry 1 ALVAREZ CESAR L · CIK 0001220297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen, Inc. common stock. Read SEC document |
| March 13, 2021 Filed Mar 16, 2021 20:37 UTC |
Frank StevenDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 62,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-000490 · edgar.xml · derivative · entry 2 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,189 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen, Inc. common stock. F2 · derivative.exercise_date: The RSUs vested in full on March 13, 2021. F2 · derivative.expiration_date: The RSUs vested in full on March 13, 2021. Read SEC document |
| March 13, 2021 Filed Mar 16, 2021 20:37 UTC |
Frank StevenDirector
|
Exercise / conversionCommon Stock | 62,189 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-000490 · edgar.xml · nonDerivative · entry 1 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,720 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen, Inc. common stock. Read SEC document |
| March 13, 2021 Filed Mar 16, 2021 20:33 UTC |
MITCHELL DEAN JDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 62,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-000485 · edgar.xml · derivative · entry 2 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,189 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen, Inc. common stock. F2 · derivative.exercise_date: The RSUs vested in full on March 13, 2021. F2 · derivative.expiration_date: The RSUs vested in full on March 13, 2021. Read SEC document |
| March 13, 2021 Filed Mar 16, 2021 20:33 UTC |
MITCHELL DEAN JDirector
|
Exercise / conversionCommon Stock | 62,189 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-000485 · edgar.xml · nonDerivative · entry 1 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen, Inc. common stock. Read SEC document |
| March 13, 2021 Filed Mar 16, 2021 20:31 UTC |
Turley James SDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 62,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-000483 · edgar.xml · derivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,189 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen, Inc. common stock. F2 · derivative.exercise_date: The RSUs vested in full on March 13, 2021. F2 · derivative.expiration_date: The RSUs vested in full on March 13, 2021. Read SEC document |
| March 13, 2021 Filed Mar 16, 2021 20:31 UTC |
Turley James SDirector
|
Exercise / conversionCommon Stock | 62,189 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-000483 · edgar.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,798 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen, Inc. common stock. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:02 UTC |
Frank StevenDirector
|
Exercise / conversionOption to Purchase Common Stock (Right to Buy) · Derivative | 2,968 | $0.00 Strike: $5.69 | $0.00 |
DisclosureSEC source: 0001123292-21-000415 · edgar.xml · derivative · entry 2 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,968 shares Expires 2021-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option was immediately exercisable. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:02 UTC |
Frank StevenDirector
|
Exercise / conversionCommon Stock | 2,968 | $5.69 | $16,887.92 |
DisclosureSEC source: 0001123292-21-000415 · edgar.xml · nonDerivative · entry 1 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:05 UTC |
ALVAREZ CESAR LDirector
|
Exercise / conversionOption to Purchase Common Stock (Right to Buy) · Derivative | 2,968 | $0.00 Strike: $5.69 | $0.00 |
DisclosureSEC source: 0001123292-21-000416 · edgar.xml · derivative · entry 2 ALVAREZ CESAR L · CIK 0001220297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,968 shares Expires 2021-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option was immediately exercisable. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:05 UTC |
ALVAREZ CESAR LDirector
|
Exercise / conversionCommon Stock | 2,968 | $5.69 | $16,887.92 |
DisclosureSEC source: 0001123292-21-000416 · edgar.xml · nonDerivative · entry 1 ALVAREZ CESAR L · CIK 0001220297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 21:58 UTC |
MITCHELL DEAN JDirector
|
Exercise / conversionOption to Purchase Common Stock (Right to Buy) · Derivative | 2,968 | $0.00 Strike: $5.69 | $0.00 |
DisclosureSEC source: 0001123292-21-000414 · edgar.xml · derivative · entry 2 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,968 shares Expires 2021-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option was immediately exercisable. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 21:58 UTC |
MITCHELL DEAN JDirector
|
Exercise / conversionCommon Stock | 2,968 | $5.69 | $16,887.92 |
DisclosureSEC source: 0001123292-21-000414 · edgar.xml · nonDerivative · entry 1 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,409 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:26 UTC |
Sabzevari HelenDirector · President and CEO
|
SaleCommon Stock | 260,045 | $8.92 | $2,318,535.22 |
DisclosureSEC source: 0001123292-21-000061 · edgar.xml · nonDerivative · entry 2 Sabzevari Helen · CIK 0001724195 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 655,214 F2 · kind: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 21:40 UTC |
Sterling Rick L.Chief Financial Officer
|
SaleCommon Stock | 6,096 | $10.56 | $64,403.63 |
DisclosureSEC source: 0001123292-21-000058 · edgar.xml · nonDerivative · entry 2 Sterling Rick L. · CIK 0001583123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,020 F2 · kind: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 21:31 UTC |
Lehr Donald P.Chief Legal Officer
|
SaleCommon Stock | 9,677 | $10.56 | $102,236.54 |
DisclosureSEC source: 0001123292-21-000055 · edgar.xml · nonDerivative · entry 2 Lehr Donald P. · CIK 0001583187 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,652 F2 · kind: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 21:37 UTC |
Sabzevari HelenDirector · President and CEO
|
SaleCommon Stock | 9,040 | $10.56 | $95,506.70 |
DisclosureSEC source: 0001123292-21-000057 · edgar.xml · nonDerivative · entry 2 Sabzevari Helen · CIK 0001724195 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415,259 F2 · kind: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 21:34 UTC |
Perez Jeffrey ThomasSVP, IP Affairs
|
SaleCommon Stock | 9,049 | $10.56 | $95,601.78 |
DisclosureSEC source: 0001123292-21-000056 · edgar.xml · nonDerivative · entry 2 Perez Jeffrey Thomas · CIK 0001617812 · SVP, IP Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,821 F2 · kind: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 21:26 UTC |
Sabzevari HelenDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-000061 · edgar.xml · derivative · entry 3 Sabzevari Helen · CIK 0001724195 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: The RSUs were granted on January 5, 2020 and have vested in full. F3 · derivative.expiration_date: The RSUs were granted on January 5, 2020 and have vested in full. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 21:26 UTC |
Sabzevari HelenDirector · President and CEO
|
Exercise / conversionCommon Stock | 500,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-000061 · edgar.xml · nonDerivative · entry 1 Sabzevari Helen · CIK 0001724195 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 915,259 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:35 UTC |
Lehr Donald P.Chief Legal Officer
|
SaleCommon Stock | 5,271 | $10.16 | $53,553.36 |
DisclosureSEC source: 0001123292-21-000036 · edgar.xml · nonDerivative · entry 2 Lehr Donald P. · CIK 0001583187 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,389 F2 · kind: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.